Suppression of NF-kappaB and NF-kappaB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IkappaB phosphorylation inhibitor) in experimental diabetic neuropathy.
Inflammation is an emerging patho-mechanism of diabetes and its complications. NF-kappaB pathway is one of the central machinery initiating and propagating inflammatory responses. The present study envisaged the involvement of NF-kappaB inflammatory casca.....